Brief: Fluicell Says In-vivo Trials Indicate High Tolerance of Implant Biomaterials

Fluicell AB

16/01/2024 08:04

Jan 16 (Reuters) - Fluicell AB  FLUIC.ST :
    * RESULTS FROM IN-VIVO TRIALS SHOW GOOD TOLERABILITY OF
BIOMATERIALS, PROCESSES CO USES IN ITS IMPLANTS

Source text for Eikon:  ID:nWkr7kTHz0 
Further company coverage:  FLUIC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))